|
SCARSDALE, NY--(Marketwired - July 12, 2016) - Sapience Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics to address difficult to treat oncology indications, announced that it has raised $22.5 million in a Series A financing. Sapience issued shares of its common stock in the financing. |
